Description
– What It Does: Examines 75 genes in tumour tissues for targeted therapy options. Ideal for tumours with known molecular targets- hemangiosarcoma, histiocytic sarcoma, osteosarcoma, oral squamous cell carcinoma, urothelial or prostatic carcinomas.
– How to Use: Provide five 5 um sections of the tumour, ensuring at least 30% tumour content or at least 3 cellular slides
– Results Timeline: Up to 14 working days from sample receipt.
– Key Feature: In-depth analysis for personalised cancer treatment strategies in cancer types with known therapeutic targets
